Tranexamic acid for reducing mortality in emergency and urgent surgery
There is evidence that tranexamic acid reduces blood transfusion in patients undergoing emergency or urgent surgery.
Emergency or urgent surgery, which can be defined as surgery which must be done promptly to save life, limb, or functional capacity, is associated with a high risk of bleeding and death. Antifibrinolytic agents, such as tranexamic acid, inhibit blood clot breakdown (fibrinolysis) and can reduce perioperative bleeding. Tranexamic acid has been shown to reduce the need for a blood transfusion in adult patients undergoing elective surgery but its effects in patients undergoing emergency or urgent surgery is unclear. This review assesses the effects of tranexamic acid on mortality, blood transfusion and thromboembolic events in adults undergoing emergency or urgent surgery.
Adults, Both sexes (for groups of both male and female persons), Cardiovascular conditions, Conflict, Earthquake, Extreme violence/Accidents, Health, Injuries (all), Neoplasms and hematologic conditions, Orthopedic injuries, Other injuries, Skin infections